PedAM
Pediatric Disease Annotations & Medicines
| Disease | hepatitis |
| Phenotype | C0002871|anemia |
| Sentences | 27 |
| PubMedID- 21643422 | In the cbv/lpv/r arm, two patients suffered from gastrointestinal discomfort, one developed anemia during co-administration of ribavirin for hepatitis c therapy and another one was admitted to hospital for an airway infection. |
| PubMedID- 23924660 | Effects of ribavirin dose reduction vs erythropoietin for boceprevir-related anemia in patients with chronic hepatitis c virus genotype 1 infection--a randomized trial. |
| PubMedID- 21611106 | On the other hand, ebv-associated hepatitis could occur with aplastic anemia [1]. |
| PubMedID- 21352606 | hepatitis associated with aplastic anemia may be acute and chronic [7], mild and transient [16], self-limiting and fulminant and the development of aa is always fatal if not treated on time [7,10]. |
| PubMedID- 24792633 | Giant cell hepatitis with autoimmune hemolytic anemia in children: proposal for therapeutic approach. |
| PubMedID- 22040235 | Now the drug is amongst the top selling pharmaceutical product worldwide and considered applicable for a variety of disorders such as anemia associated with renal failure, hepatitis c infection, cancer, human immunodeficiency virus infections, and cardiovascular disease [6]. |
| PubMedID- 22988553 | [clinical features of aplastic: anemia patients with hepatitis b virus infection: a case report of 12 patients]. |
| PubMedID- 23226068 | A randomized trial comparing ribavirin dose reduction with administration of erythropoietin for the management of anemia in patients with chronic hepatitis c receiving boceprevir and peg-ifn-α-ribavirin has shown similar sustained virological response rates and safety profiles in both groups.51 therefore, reduction of the ribavirin dose in patients treated with peg-ifn-α-ribavirin and boceprevir appears to be an appropriate way to manage anemia. |
| PubMedID- 25201797 | Giant cell hepatitis with autoimmune hemolytic anemia (gch-aha) is a rare autoimmune disease of infancy characterized by severe liver disease associated with coombs-positive hemolytic anemia. |
| PubMedID- 22181672 | Efficacy of splenectomy in preventing anemia in patients with recurrent hepatitis c following liver transplantation is not dependent on inosine triphosphate pyrophosphatase genotype. |
| PubMedID- 23969541 | Background and aims: giant cell hepatitis with autoimmune hemolytic anemia (gch-aha) is presumed to be an autoimmune disease, but the mechanism of liver injury is unknown. |
| PubMedID- 21349541 | Objective: to assess the outcome of giant cell hepatitis combined with autoimmune hemolytic anemia in early childhood. |
| PubMedID- 23945605 | It has long been recognized that clinical response is not solely dependent on pk, but there are many other factors relating to the status of the hiv-positive patient that also play a role.4,5 this has clearly been shown to be the case for maraviroc particularly when focusing on overall virologic success.2 for this reason, generalized additive models (gams) were employed to characterize the influence of prognostic factors (including exposure parameters) on sustained virologic response and incidence of anemia in patients with chronic hepatitis c6 and in hiv-1–infected patients in the etravirine phase iii clinical studies.7 gams allow potential predictors to enter linearly or nonlinearly, as appropriate for each case. |
| PubMedID- 20698227 | Conclusion: this is the first study in the literature investigating a link between angiogenesis soluble markers and ribavirin induced anemia in patients with hepatitis c and we could not find any relation. |
| PubMedID- 21346688 | Role of nucleoside transporters slc28a2/3 and slc29a1/2 genetics in ribavirin therapy: protection against anemia in patients with chronic hepatitis c. |
| PubMedID- 23671728 | Giant cell hepatitis with autoimmune hemolytic anemia in a nine month old infant. |
| PubMedID- 21516016 | Although fulminant hepatitis with nonimmune hemolytic anemia is frequently reported, chronic mild hepatitis can occur with bouts of transient hemolytic anemia. |
| PubMedID- 24879173 | Severe autoimmune hemolytic anemia in a patient with chronic hepatitis c during treatment with peg interferon alfa-2a and ribavirin. |
| PubMedID- 22087146 | Pernicious anemia in case of chronic viral hepatitis infection: pernicious anemia and chronic viral hepatitis. |
| PubMedID- 21332002 | Autoimmune hemolytic anemia with giant cell hepatitis is a distinct entity in children. |
| PubMedID- 26138133 | Background and objective: giant cell hepatitis with autoimmune hemolytic anemia (gch-aha) is a rare disease of infancy, of possible autoimmune mechanism with poor prognosis due to its scarce response to immunosuppressive drugs. |
| PubMedID- 22931407 | Hla-b*15:02 is associated with anemia in patients with chronic hepatitis c treated with pegylated interferon-alpha and ribavirin. |
| PubMedID- 22097608 | Conclusion: main treatments of viral hepatitis combined with aplastic anemia were to treat primary hepatopathy and nucleoside analogue-based antiviral therapy, to provide symptomatic and supportive treatment for blood diseases. |
| PubMedID- 25834588 | Background: single-nucleotide polymorphisms (snp) in the inosine triphosphate pyrophosphatase (itpa) gene correlate with ribavirin (rbv)-induced anemia in patients with chronic hepatitis c (chc) receiving combination therapy. |
| PubMedID- 23386076 | anemia management in patients with chronic viral hepatitis c. |
| PubMedID- 25032187 | Pure red-cell aplasia and autoimmune hemolytic anemia in a patient with acute hepatitis a. |
| PubMedID- 21891998 | [autoimmune hemolytic anemia in a case of chronic hepatitis type c 56 weeks after initiation of second line treatment with pegylated interferon alpha2b/ribavirin combination therapy]. |
Page: 1